FDA Inspection 1323220 — Nippon Sanso Matheson, Inc.

Nippon Sanso Matheson, Inc. — FEI 3001451839

The FDA completed an inspection of Nippon Sanso Matheson, Inc. on Jun 4, 2026 in Lawton, OK. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 4, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lawton, OK (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.